We are experts in epigenetic biomarker research and their potential applications in diagnostic, prognosis and treatment monitoring. EpiDisease has developed Standard Operating Procedures to prepare biospecimens, purify epigenetic markers and proceed to highthroughput analysis using technologies such as Next Generation Sequencing, EPIC methylation arrays and mass spectrometry.
Our Bioinformatics services include:
